Our Kulmbach site recently welcomed 50 students from the Coburg University offering them an in-depth look at our facilities and the opportunity to meet some of our scientists. The students gained valuable insights into our support for world-leading custom research in the preclinical and clinical development of genetic-level therapeutics. Additionally, they learned about the diverse career opportunities available in science. Thank you to all the colleagues who contributed to making this visit so engaging. A special thank you to all the students for their visit and inspiring conversations. We look forward to following your careers and hope to welcome some of you to our team in the future! #ScienceCareers #STEM #Hiring #Germany
Axolabs GmbH
Biotechnologieforschung
Kulmbach, Bayern 2.548 Follower:innen
SERVING OLIGONUCLEOTIDE THERAPEUTICS
Info
Axolabs hat sich auf eine neue Klasse von Medikamenten spezialisiert, deren Wirkstoffe sich chemisch von DNA oder RNA ableiten. Sie werden als Oligonukleotid- bzw. Nukleinsäure-Therapeutika bezeichnet. Mit unserer langjährigen Expertise helfen wir unseren Kunden dabei, diese zum Erfolg zu führen. Einige dieser Medikamente sind bereits zugelassen und werden gegen bisher teils unbehandelbare Krankheiten erfolgreich eingesetzt. Jedes Jahr kommen neue Medikamente aus dieser Klasse hinzu. Axolabs gehört zur LGC-Gruppe. Deren Business Unit für Nukleinsäure-Therapeutika wird unter dem Markennamen Axolabs zusammengefasst. Axolabs betreibt Firmen an folgenden Standorten: Axolabs GmbH, Kulmbach, Deutschland Die Axolabs GmbH ist die weltweit führende Auftragsforschungsorganisation auf dem Gebiet der Nukleinsäuretherapeutika mit einer breiten Palette von Leistungen. Axolabs Berlin, Berlin, Deutschland Axolabs baut derzeit einen neuen Standort in Berlin für die GMP-Herstellung von Nukleinsäuretherapeutika auf. Der Standort ist für die klinische GMP-Herstellung von Nukleinsäuretherapeutika im mittleren bis großen Maßstab und in der frühen bis späten Phase vorgesehen. Die hochmoderne Anlage wird integrierte Analyse- und Syntheselösungen liefern. Die Betriebsaufnahme ist für das Jahr 2024 geplant. Axolabs Petaluma, Petaluma, Kalifornien, USA Axolabs betreibt in Petaluma eine Anlage zur cGMP-Produktion von Oligonukleotid-Wirkstoffen für technische, toxikologische und präklinische bis hin zu späten klinischen Studien.
- Website
-
http://www.axolabs.com
Externer Link zu Axolabs GmbH
- Branche
- Biotechnologieforschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Kulmbach, Bayern
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2011
- Spezialgebiete
- Oligonucleotide Therapeutics, Oligonucleotide Synthesis und Bioanalytics
Orte
-
Primär
Wegbeschreibung
Fritz-Hornschuch Straße 9
Kulmbach, Bayern 95326, DE
-
Wegbeschreibung
Wolfener Straße 23
Berlin, BE 12681, DE
-
Wegbeschreibung
2199 S McDowell Blvd
Petaluma, California 94954, US
Beschäftigte von Axolabs GmbH
-
Christian O. A. Reiser, PhD
Director, Head of Business Development at Axolabs GmbH
-
Marc Jobert
IT Expert for all Systems supporting Pharmaceutical R&D
-
Thomas Rupp
Managing Director Technical Operations
-
Adeline Espinasse, Ph.D.
Therapeutic Manufacturing Associate Director at Axolabs, LGC
Updates
-
For our next event we will be in Milan for IOPC! There is still time to register at https://lnkd.in/db-qE-sX Hope to see you there! #IOPC #Oligos #NucleicAcidTherapeutics
🔔 The #IOPC Community is waiting for you!🔔 Last days to register ⌛! Highlights: ✔️ June 25th morning: Plenary Session by Lars Holmberg and Joint #Oligo & #Peptide Session by Thomas Müller-Späth 🎤 ✔️June 25th from 1PM: track on Peptides in #Cosmetic covering state of art, applications, perspectives and case-studies 🆕 ✔️ June 25th and 26th: Conference and Exhibition 🎙 ✔️ June 25th from 7pm: Business #Networking Event at Rotonda Bistro 🎶 🥂 Register now and don't miss out 🏃♂️ : https://www.iopc-tks.com/ 📅 Date: 25-26 June 📍 Location: Milan, nHow Hotel For scientific content inquiries, please contact Monica Nizzardo For sponsorship opportunities, please contact Matteo Cattane Sponsor: 💎DIAMOND: Thermo Fisher Scientific 🥇 GOLD: Agilent Technologies, AmbioPharm - A Global Peptide CDMO, EUROAPI, PolyPeptide Group, Tosoh Corporation, AMETEK, DuPont, Sinopep-Allsino Biopharmaceutical Co., Ltd. 🥈SILVER: Asymchem Group, BioSpring GmbH, Neuland Laboratories Limited, Gyros Protein Technologies, WuXi Chemistry, Vapourtec Ltd, PeptiSystems AB, Eurogentec, Axolabs, Gilson, Biotage, Biosynth, CEM Corporation, Milestone Technologies, Inc., ChemGenes, Zhejiang Jiuzhou Pharmaceutical Co., Ltd., Microsynth AG, QUALITY ASSISTANCE S.A. #weareTKS
-
-
If you didn't attend TIDES US our scientific posters are available on our website! Visit https://lnkd.in/eQgq5RyR #NucleicAcidTherapeutics #Oligos #TIDESUSA Shiva Adhikari, PhD
-
-
Yesterday was super busy on the booth plus a great talk by Ingo Röhl & Songjun Xiao #TIDESUSA #NucleicAcidTherapeutics #sgRNA #Oligos
Great D2. Thank you to everyone who stopped by today. We were excited to hear about the continued development in Therapeutics #TIDES24 #AXOlabs #LGC
-
-
We have some friends with us this year on our booth at TIDES! You're welcome to give one of our axolotls a good home #TIDESUSA #NucleicAcidTherapeutics #Oligos
-
-
Axolabs GmbH hat dies direkt geteilt
In case you don't spot us we're at booth 207 😉 #TIDESUSA
-
-
In case you don't spot us we're at booth 207 😉 #TIDESUSA
-
-
We're TIDES US 2024 ready and looking forward to meeting everyone over the next few days! #TIDESUSA #NucleicAcidTherapeutics #Oligos
-
-
Did you know that as well as providing world-leading discovery & pre-clinical solutions our capabilities also include high quality manufacturing of nucleic acid therapeutics and related services. #NucleicAcidTherapeutics #Oligos #GMP #Manufacturing
-
Introducing our latest bioanalytical service: Liquid Chromatography-Mass Spectrometry (LC-MS) for cutting-edge bioanalysis of oligonucleotides With LC-MS/MS technology, we deliver precise quantification of DNA- or RNA-based therapeutics and their metabolites directly from biological samples with high specificity. Our state-of-the-art triple quadrupole mass spectrometer enables multiple reaction monitoring (MRM) and therefore high sensitivity. We’ve streamlined the process with our generic extraction procedures for antisense oligonucleotides (ASOs), aptamers, and small interfering RNAs (siRNAs). This allows for a rapid method development of a wide range of analytes in various liquid and solid matrices. Right now, we’re offering this ground-breaking bioanalytical service in a non-regulated environment. But we’re not stopping there! By end of 2024, we’ll be offering LC-MS/MS bioanalysis accordance with the ICH M10 guideline. Please see: https://lnkd.in/e9mt5gV9 #Oligonucleotides #NucleicAcidTherapeutics #Bioanalytics
-